Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma—An Easy Question Turned Difficult: Treat the Scan or the Patient?

Tim J. Kruser; Minesh P. Mehta; Kevin R. Kozak

doi:10.1200/JCO.2015.64.7883

Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma—An Easy Question Turned Difficult: Treat the Scan or the Patient?

Tim J. Kruser, Minesh P. Mehta, Kevin R. Kozak

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	34
DOIs	https://doi.org/10.1200/JCO.2015.64.7883
State	Published - Apr 10 2016

Disciplines

Medicine and Health Sciences
Surgery
Pathology
Immunology and Infectious Disease

Access to Document

10.1200/JCO.2015.64.7883License: Unspecified

Cite this

@article{a3ed78c062364d02af1e6367198cddfb,

title = "Identification of Patients Who Benefit From Bevacizumab in High-Grade Glioma—An Easy Question Turned Difficult: Treat the Scan or the Patient?",

author = "Kruser, \{Tim J.\} and Mehta, \{Minesh P.\} and Kozak, \{Kevin R.\}",

note = "In order to access this website, please configure your browser to support cookies.",

year = "2016",

month = apr,

day = "10",

doi = "10.1200/JCO.2015.64.7883",

language = "American English",